Refine by
Hematology Suppliers In Austria
6 companies found
based inWr. Neudorf,, AUSTRIA
DIALAB® GmbH was founded in 1972 as a trading company for pipettes and scales with its headquarters in Vienna. In the early 1990s, DIALAB® started with the production of diagnostic reagents. In 2005, DIALAB® relocated its headquarters and main ...
Form: Liquid, ready to use, Method: Impedancemetry, Sample: Whole blood, No. of cycles: ...
based inWiener Neudorf, AUSTRIA
West Medica feels strongly that innovation is the key to a brighter future and improves the quality of life for everyone. Development of Vision solutions for digital microscopy is a top priority and the main focus of West Medica. Technology is an ...
based inKraainem, BELGIUM
With over 17,000 staff in around 200 laboratories across 36 countries, Eurofins Scientific is the world leader in food and biopharma product testing. It is also number one in the world in the field of environmental laboratory services and one of the ...
based inNorwood, MASSACHUSETTS (USA)
Advanced Instruments is dedicated to increasing productivity and ensuring quality in the biotechnology, pharmaceutical, clinical and food & beverage industries. With a focus on innovations that anticipate and overcome customer pain points, we help ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
Natural killer (NK) cells are innate lymphocytes that kill virally infected or malignant cells. Unlike T cells, NK cells function in an antigen independent manner, responding to anything they perceive as "non-self", including malignant cells. NK ...
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
At the ISTH 2020 Biotest presented its novel recombinant Factor VIII molecules overcoming the major challenges of current Factor VIII replacement therapy by combining a significantly extended half-life, low immunogenicity and the possibility of ...